Trademark Overview
On Thursday, June 22, 2023, a trademark application was filed for PROVEN with the United States Patent and Trademark Office. The USPTO has given the PROVEN trademark a serial number of 98055522. The federal status of this trademark filing is RESPONSE AFTER NON-FINAL ACTION - ENTERED as of Saturday, August 2, 2025. This trademark is owned by Entity Risk, Inc.. The PROVEN trademark is filed in the Computer & Software Products & Electrical & Scientific Products, Advertising, Business and Retail Services, and Computer & Software Services & Scientific Services categories with the following description:
Computer software platforms, downloadable, for innovators to predict asset values, determine pricing, evidence-generation, and contracting by utilizing a pricing and generalized value module and commercial due diligence module; Computer software platforms, downloadable, for simulating, forecasting, and analyzing product value, pricing, clinical effectiveness, and commercial viability of medical treatments; Computer software platforms, downloadable, for supporting payer engagement, value-based care strategies, and evidence-generation planning.
Design, development, and implementation of software for innovators to predict asset values, determine pricing, evidence-generation, and contracting by utilizing a pricing and generalized value module and commercial due diligence module; Providing online non-downloadable computer software platforms for simulating and analyzing clinical and commercial scenarios to support drug pricing, value assessment, evidence generation, and payer engagement in the healthcare and biopharmaceutical industries; Providing an interactive website featuring technology that allows users to enter, access, and synthesize information and generate reports for use in consulting with executives and businesses; Software as a service (SAAS) services featuring software for predicting business asset values, determining pricing, evidence-generation, and contracting by utilizing a pricing and generalized value module and commercial due diligence module.
Design, development, and implementation of software for innovators to predict asset values, determine pricing, evidence-generation, and contracting by utilizing a pricing and generalized value module and commercial due diligence module; platform for building recommendations based on clinical evidence of benefit and risk; platform which expedites value assessment and provides qualitative, evidence based approach to support decisions about pricing, evidence generation and contracting.; Providing an interactive website featuring technology that allows users to enter, access, and synthesize information and generate reports for use in consulting with executives and businesses; Software as a service (SAAS) services featuring software for predicting business asset values, determining pricing, evidence-generation, and contracting by utilizing a pricing and generalized value module and commercial due diligence module
